CMIT encompasses a wide-range of talents, skills, and resources in the science of molecular imaging and therapy. We combine research, radiopharmaceutical manufacturing and molecular imaging and therapy into a highly capable, organization. Our team can tackle projects from multiple angles providing innovative and sometimes unexpected results.
CMIT, through Southern Isotopes, provide radiopharmaceuticals to imaging centers throughout the region while the PET Imaging Center provides direct patient care for thousands of patients each year. In addition, CMIT engages in cutting-edge clinical trials which offers access to experimental procedures to area patients.
CMIT collaborates with researchers from other organizations to conduct preclinical, translational and clinical research in order to further discovery of new knowledge. We develop new chemistry, radio-labeling methods, biologic target designs, and imaging procedures to answer functional questions and to improve healthcare.